Literature DB >> 7054189

Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation.

D T Connolly, R R Townsend, K Kawaguchi, W R Bell, Y C Lee.   

Abstract

Synthetic cluster glycosides containing either one, two, or three galactosyl or lactosyl residues per ligand were used to test the effect of carbohydrate clustering on binding by the rabbit hepatic Gal/GalNAc-binding lectin using either isolated rabbit hepatocytes or the solubilized, affinity-purified lectin. The tris- and bis-glycosides were superior to the mono-glycosides for inhibition of 125I-asialoorosomucoid binding to rabbit hepatocytes at 0 degrees C. The concentrations of the tris-glycosides required for 50% inhibition of 125I-asialoorosomucoid binding (4-8 microM) to hepatocytes were 50-100 times lower than the concentrations of the corresponding mono-glycosides required for 50% inhibition (400-500 microM). The isolated lectin, however, did not effectively discriminate between the mono-, bis-, and tris-glycosides, possibly indicating an organizational difference between the lectin in the cell membrane and the isolated lectin. When the cluster glycosides were labeled with 125I-tyrosine, it was shown that the tris- and bis-galactosides were bound to the hepatocytes at 37 degrees C, and that binding was followed by a step that led to ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid resistance, probably internalization. The process could be specifically inhibited by the neoglycoprotein Gal44-AI-bovine serum albumin, or by IgG specific for the hepatic lectin, but not by preimmune IgG. Internalization of the cluster glycosides did not lead to accumulation of ligand inside the cell, nor to degradation. Instead, the ligands were quickly released from the cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054189

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Characterization of retroendocytosis in rat liver parenchymal cells and sinusoidal endothelial cells.

Authors:  S Magnusson; I Faerevik; T Berg
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development.

Authors:  Mariano Severgnini; Jennifer Sherman; Alfica Sehgal; Narayanannair K Jayaprakash; Justin Aubin; Gang Wang; Ligang Zhang; Chang G Peng; Kristina Yucius; Jim Butler; Kevin Fitzgerald
Journal:  Cytotechnology       Date:  2011-11-22       Impact factor: 2.058

Review 3.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

4.  Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.

Authors:  Swati A Guhagarkar; Sharmila B Majee; Abdul Samad; Padma V Devarajan
Journal:  Cancer Nanotechnol       Date:  2011-01-27

5.  The two subunits of the human asialoglycoprotein receptor have different fates when expressed alone in fibroblasts.

Authors:  M A Shia; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapy.

Authors:  Sarah M Cheal; Barney Yoo; Sarah Boughdad; Blesida Punzalan; Guangbin Yang; Anna Dilhas; Geralda Torchon; Jun Pu; Don B Axworthy; Pat Zanzonico; Ouathek Ouerfelli; Steven M Larson
Journal:  Mol Pharm       Date:  2013-11-23       Impact factor: 4.939

7.  Rapid release of galactose-terminated ligands after endocytosis by hepatic parenchymal cells: evidence for a role of carbohydrate structure in the release of internalized ligand from receptor.

Authors:  R R Townsend; D A Wall; A L Hubbard; Y C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 8.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

9.  Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.

Authors:  Shintaro Fumoto; Fumi Nakadori; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

10.  Synthesis of neoglycopeptides and analyses of their biodistribution in vivo to identify tissue specific uptake and novel putative membrane lectins.

Authors:  D Gupta; A Surolia
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.